Hot Keywords
non-alcoholic fatty liver disease epidemiology microenvironment nonalcoholic steatohepatitis transplantation cholangiocarcinoma direct-acting antiviral immunotherapy hepatitis B hepatitis C liver resection imaging cancer stem cell diagnosis gene cirrhosis biomarker recurrence

The paper's citation list
No.The paper's citation list
1YAP inactivation in estrogen receptor alpha-positive hepatocellular carcinoma with less aggressive behavior. 2021;53:1055 doi: 10.1038/s12276-021-00639-2
2Chemopreventive Effect of Statin on Hepatocellular Carcinoma in Patients With Nonalcoholic Steatohepatitis Cirrhosis. 2021;116:2258 doi: 10.14309/ajg.0000000000001347
3Effects of surgery, chemotherapy, and radiation on hepatocellular carcinoma patients: A SEER-based study. 2021;69:102782 doi: 10.1016/j.amsu.2021.102782
4Hepatocellular carcinoma as predominant cancer subgroup accounting for sex differences in post-hepatectomy liver failure, morbidity and mortality. 2022; doi: 10.1016/j.hpb.2022.02.009
5New Biological Insights on X and Y Chromosome-Bearing Spermatozoa. 2020;7: doi: 10.3389/fcell.2019.00388
6Inducible Liver Cancer Models in Transgenic Zebrafish to Investigate Cancer Biology. 2021;13:5148 doi: 10.3390/cancers13205148
7Gender disparity in hepatocellular carcinoma recurrence after curative hepatectomy. 2022;27:100695 doi: 10.1016/j.aohep.2022.100695
8Characteristic Features of Nonalcoholic Fatty Liver Disease in Japan with a Focus on the Roles of Age, Sex and Body Mass Index. 2020;14:537 doi: 10.5009/gnl19236
9Estrogen Receptor 1 Inhibition of Wnt/β-Catenin Signaling Contributes to Sex Differences in Hepatocarcinogenesis. 2021;11: doi: 10.3389/fonc.2021.777834
10Clinical impact of sexual dimorphism in non‐alcoholic fatty liver disease (NAFLD) and non‐alcoholic steatohepatitis (NASH). 2021;41:1713 doi: 10.1111/liv.14943
11MXD3 Promotes Obesity and the Androgen Receptor Signaling Pathway in Gender-Disparity Hepatocarcinogenesis. 2021;10:3434 doi: 10.3390/cells10123434
12Vascular Endothelial Growth Factor Levels Difference among Hepatocellular Cancer Patients Based on Barcelona Clinic Liver Cancer Staging. 2021;9:797 doi: 10.3889/oamjms.2021.6598
13Assessment of risk factors, and racial and ethnic differences in hepatocellular carcinoma. 2020;4:351 doi: 10.1002/jgh3.12336
14Sex-Biased Molecular Signature for Overall Survival of Liver Cancer Patients. 2020;28:491 doi: 10.4062/biomolther.2020.157
15Longitudinal studies can identify distinct inflammatory cytokines associated with the inhibition or progression of liver cancer. 2020;40:468 doi: 10.1111/liv.14323
16What Do We Know about Inequalities in NAFLD Distribution and Outcomes? A Scoping Review. 2021;10:5019 doi: 10.3390/jcm10215019
17Sex-dependent liver cancer xenograft models for predicting clinical data in the evaluation of anticancer drugs. 2021;37: doi: 10.1186/s42826-021-00087-z
18External validation of the Toronto hepatocellular carcinoma risk index in a Swedish population. 2021;3:100343 doi: 10.1016/j.jhepr.2021.100343
19Matching mouse models to specific human liver disease states by comparative functional genomics of mouse and human datasets. 2022;1865:194785 doi: 10.1016/j.bbagrm.2021.194785
20Changing epidemiology of hepatocellular carcinoma in Asia. 2022; doi: 10.1111/liv.15251
21Current epidemiology in hepatocellular carcinoma. 2021;15:1295 doi: 10.1080/17474124.2021.1991792
22Transcatheter arterial chemoembolization combined with microwave ablation for treatment of early liver cancer: Efficacy and prognostic factors for progression-free survival. 2019;27:1201 doi: 10.11569/wcjd.v27.i19.1201
23Sex Differences in the Incidence of Obesity-Related Gastrointestinal Cancer. 2021;22:1253 doi: 10.3390/ijms22031253
24. ; doi:
25Practitioner availability rather than surgical quality impacts the utilization of liver transplantation for hepatocellular carcinoma. 2021;23:861 doi: 10.1016/j.hpb.2020.12.012
26Global pattern of trends in incidence, mortality, and mortality-to-incidence ratio rates related to liver cancer, 1990–2019: a longitudinal analysis based on the global burden of disease study. 2022;22: doi: 10.1186/s12889-022-12867-w
27Glutathione S-Transferase P1 Polymorphism on Exon 6 and Risk of Hepatocellular Carcinoma in Thai Male Patients. 2020;98:243 doi: 10.1159/000505213
28Aflatoxin B1 exposure and liver cirrhosis in Guatemala: a case–control study. 2020;7:e000380 doi: 10.1136/bmjgast-2020-000380
29Intelligent Analysis of Some Factors Accompanying Hepatitis B. 2022;2:61 doi: 10.37394/232023.2022.2.7
30NAFLD-Associated HCC: Progress and Opportunities. 2021;Volume 8:223 doi: 10.2147/JHC.S272213
31The Potential Gut Microbiota-Mediated Treatment Options for Liver Cancer. 2020;10: doi: 10.3389/fonc.2020.524205
32A Review of the Current State of Liver Transplantation Disparities. 2021;27:434 doi: 10.1002/lt.25964
33SERMs (selective estrogen receptor modulator), acting as estrogen receptor β agonists in hepatocellular carcinoma cells, inhibit the transforming growth factor-α-induced migration via specific inhibition of AKT signaling pathway. 2022;17:e0262485 doi: 10.1371/journal.pone.0262485
34Racial and Sex Disparities in Hepatocellular Carcinoma in the USA. 2020;19:462 doi: 10.1007/s11901-020-00554-6
35Health Disparities in Screening, Diagnosis, and Treatment of Hepatocellular Carcinoma. 2021;17:353 doi: 10.1002/cld.1057
36Overexpression of Galectin-1 and Galectin-3 in hepatocellular carcinoma. 2020;4:173 doi: 10.1016/j.livres.2020.11.001
37Sugar Alcohols Have a Key Role in Pathogenesis of Chronic Liver Disease and Hepatocellular Carcinoma in Whole Blood and Liver Tissues. 2020;12:484 doi: 10.3390/cancers12020484
38The immunological and metabolic landscape in primary and metastatic liver cancer. 2021;21:541 doi: 10.1038/s41568-021-00383-9
39NAFLD in Women: Unique Pathways, Biomarkers, and Therapeutic Opportunities. 2019;18:425 doi: 10.1007/s11901-019-00495-9
40. ; doi:
41Sociodemographic Characteristics as Predictors of Outcomes in Hepatocellular Carcinoma: A Retrospective Cohort Study. 2020;27:107327482095661 doi: 10.1177/1073274820956615
42Current and Future Scenario of Immunotherapy for the Treatment of Hepatocellular Carcinoma. 2021;17:148 doi: 10.2174/1573394716999200818103724
43Involvement of Kynurenine Pathway in Hepatocellular Carcinoma. 2021;13:5180 doi: 10.3390/cancers13205180
44Sex disparities in presentation and prognosis of 1110 patients with hepatocellular carcinoma. 2020;52:701 doi: 10.1111/apt.15917
45Differential prognoses among male and female patients with hepatocellular carcinoma. 2022;85:554 doi: 10.1097/JCMA.0000000000000722
46Gender Matters: Characteristics of Hepatocellular Carcinoma in Women From a Large, Multicenter Study in the United States. 2020;115:1486 doi: 10.14309/ajg.0000000000000643
47The variable association between expression and methylation of estrogen receptors and the survival of patients with different tumors. 2020;10: doi: 10.1002/ctm2.49
48Gender Disparity in Host Responses to Hepatitis B-Related Hepatocellular Carcinoma: A Case Series. 2021;9:838 doi: 10.3390/vaccines9080838
© 2016-2022 OAE Publishing Inc., except certain content provided by third parties